{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T23:07:56Z","timestamp":1789945676400,"version":"4.0.1"},"reference-count":72,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progr\u00e8s en Urologie"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.purol.2014.06.010","type":"journal-article","created":{"date-parts":[[2014,7,30]],"date-time":"2014-07-30T17:01:13Z","timestamp":1406739673000},"page":"943-953","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Voies de carcinogen\u00e8se et histoire naturelle des tumeurs de la voie excr\u00e9trice sup\u00e9rieure\u00a0: \u00e9tat de l\u2019art pour le rapport annuel de l\u2019Association fran\u00e7aise d\u2019urologie"],"prefix":"10.1016","volume":"24","author":[{"given":"T.","family":"Seisen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Cancel-Tassin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Colin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Cussenot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Roupr\u00eat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.purol.2014.06.010_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijc.10544","article-title":"Clonality of multifocal urothelial carcinomas: 10 years of molecular genetic studies","volume":"101","author":"Hafner","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.purol.2014.06.010_bib0010","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0022-5347(17)49028-8","article-title":"Upper urinary tract transitional cell carcinoma in patients with bladder carcinoma and associated vesicoureteral reflux","volume":"133","author":"Amar","year":"1985","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2014.06.010_bib0015","first-page":"611","article-title":"Reflux v\u00e9sico-r\u00e9nal apr\u00e8s traitement endoscopique des tumeurs v\u00e9sicales et complications th\u00e9rapeutiques","volume":"92","author":"Mazeman","year":"1986","journal-title":"J Urol (Paris)"},{"key":"10.1016\/j.purol.2014.06.010_bib0020","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.eururo.2006.11.025","article-title":"On the origin of syn- and metachronous urothelial carcinomas","volume":"51","author":"H\u00f6glund","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2014.06.010_bib0025","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1056\/NEJM199203123261104","article-title":"Clonal origin bladder cancer","volume":"326","author":"Sidransky","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.purol.2014.06.010_bib0030","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/0140-6736(93)92066-3","article-title":"Metachronous multifocal development of urothelial cancers by intraluminal seeding","volume":"342","author":"Habuchi","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.purol.2014.06.010_bib0035","first-page":"1795","article-title":"Molecular screening of multifocal transitional cell carcinoma of the bladder using p53 mutations as biomarkers","volume":"2","author":"Xu","year":"1996","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.purol.2014.06.010_bib0040","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/S0022-5347(01)65550-2","article-title":"Clonal analysis of human recurrent superficial bladder cancer by immunohistochemistry of P53 and retinoblastoma proteins","volume":"156","author":"Chern","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2014.06.010_bib0045","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000055919","article-title":"Oligoclonality of early lesions of the urothelium as determined by microdissection supported genetic analysis","volume":"68","author":"Stoehr","year":"2000","journal-title":"Pathobiol J Immunopathol Mol Cell Biol"},{"key":"10.1016\/j.purol.2014.06.010_bib0050","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/labinvest.3780074","article-title":"Clonality and genetic divergence in multifocal low-grade superficial urothelial carcinoma as determined by chromosome 9 and p53 deletion analysis","volume":"80","author":"Hartmann","year":"2000","journal-title":"Lab Investig"},{"key":"10.1016\/j.purol.2014.06.010_bib0055","doi-asserted-by":"crossref","first-page":"4910","DOI":"10.1038\/sj.onc.1204671","article-title":"Evidence for oligoclonality and tumor spread by intraluminal seeding in multifocal urothelial carcinomas of the upper and lower urinary tract","volume":"20","author":"Hafner","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.purol.2014.06.010_bib0060","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1097\/00005392-200102000-00092","article-title":"Distinct microsatellite alterations in upper urinary tract tumors and subsequent bladder tumors","volume":"165","author":"Takahashi","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2014.06.010_bib0065","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1097\/01.ju.0000129541.23460.48","article-title":"Multifocal transitional cell carcinoma of the bladder and upper urinary tract: molecular screening of clonal origin by characterizing CD44 alternative splicing patterns","volume":"172","author":"Miyake","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2014.06.010_bib0070","doi-asserted-by":"crossref","first-page":"6512","DOI":"10.1158\/1078-0432.CCR-05-0891","article-title":"Molecular evidence supporting field effect in urothelial carcinogenesis","volume":"11","author":"Jones","year":"2005","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"10.1016\/j.purol.2014.06.010_bib0075","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1186\/2193-1801-2-412","article-title":"Comparison of the clonality of urothelial carcinoma developing in the upper urinary tract and those developing in the bladder","volume":"2","author":"Wang","year":"2013","journal-title":"SpringerPlus"},{"key":"10.1016\/j.purol.2014.06.010_bib0080","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1093\/carcin\/14.10.2119","article-title":"p53 mutations in phenacetin-associated human urothelial carcinomas","volume":"14","author":"Petersen","year":"1993","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.purol.2014.06.010_bib0085","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.eururo.2005.03.009","article-title":"Upper urinary tract cancer: location is correlated with prognosis","volume":"48","author":"Van der Poel","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2014.06.010_bib0090","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/modpathol.3800529","article-title":"pT classification, grade, and vascular invasion as prognostic indicators in urothelial carcinoma of the upper urinary tract","volume":"19","author":"Langner","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1016\/j.purol.2014.06.010_bib0095","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.juro.2009.05.040","article-title":"The protective role of renal parenchyma as a barrier to local tumor spread of upper tract transitional cell carcinoma and its impact on patient survival","volume":"182","author":"Park","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2014.06.010_bib0100","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.eururo.2011.05.049","article-title":"Ureteral and multifocal tumours have worse prognosis than renal pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomy","volume":"60","author":"Ouzzane","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2014.06.010_bib0105","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.1111\/j.1464-410X.2011.10792.x","article-title":"Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy","volume":"110","author":"Yafi","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.purol.2014.06.010_bib0110","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.eururo.2009.07.002","article-title":"Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomy","volume":"57","author":"Raman","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2014.06.010_bib0115","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/j.juro.2009.07.035","article-title":"Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma","volume":"182","author":"Isbarn","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2014.06.010_bib0120","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.eururo.2011.07.009","article-title":"Lymphadenectomy at the time of nephroureterectomy for upper tract urothelial cancer","volume":"60","author":"Roscigno","year":"2011","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.purol.2014.06.010_bib0125","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.urology.2006.10.014","article-title":"Primary site and incidence of lymph node metastases in urothelial carcinoma of upper urinary tract","volume":"69","author":"Kondo","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.purol.2014.06.010_bib0130","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/j.1464-410X.2008.08135.x","article-title":"Lymphangiogenesis occurs in upper tract urothelial carcinoma and correlates with lymphatic tumour dissemination and poor prognosis","volume":"103","author":"Bolenz","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.purol.2014.06.010_bib0135","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1002\/cncr.21466","article-title":"Clonal origin of lymph node metastases in bladder carcinoma","volume":"104","author":"Jones","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.purol.2014.06.010_bib0140","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/bju.12116","article-title":"Impact of lymphovascular invasion on oncological outcomes in patients with upper tract urothelial carcinoma after radical nephroureterectomy","volume":"111","author":"Hurel","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.purol.2014.06.010_bib0145","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.eururo.2009.12.029","article-title":"Prognostic role of lymphovascular invasion in patients with urothelial carcinoma of the upper urinary tract: an international validation study","volume":"57","author":"Novara","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2014.06.010_bib0150","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cancergen.2012.04.008","article-title":"DNA copy number aberrations associated with lymphovascular invasion in upper urinary tract urothelial carcinoma","volume":"205","author":"Misumi","year":"2012","journal-title":"Cancer Genet"},{"issue":"6","key":"10.1016\/j.purol.2014.06.010_bib0155","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.purol.2012.01.013","article-title":"R\u00f4le pronostique des emboles vasculaires tumoraux dans les tumeurs des voies excr\u00e9trices urinaires sup\u00e9rieures\u00a0: analyse r\u00e9trospective monocentrique","volume":"22","author":"Colin","year":"2010","journal-title":"Prog Urol"},{"key":"10.1016\/j.purol.2014.06.010_bib0160","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/1471-2407-10-164","article-title":"Increased Rac1 activity and Pak1 overexpression are associated with lymphovascular invasion and lymph node metastasis of upper urinary tract cancer","volume":"10","author":"Kamai","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.purol.2014.06.010_bib0165","doi-asserted-by":"crossref","first-page":"E28","DOI":"10.1111\/bju.12133","article-title":"Patient characteristics and outcomes in metastatic upper tract urothelial carcinoma after radical nephroureterectomy: the experience of Japanese multi-institutions","volume":"112","author":"Tanaka","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.purol.2014.06.010_bib0170","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1464-410X.2008.07985.x","article-title":"Transitional cell carcinomas of the renal pelvis and the ureter: comparative demographic characteristics, pathological grade and stage and 5-year survival in a Taiwanese population","volume":"103","author":"Tan","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.purol.2014.06.010_bib0175","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0090-4295(00)00574-4","article-title":"Molecular diagnosis of metastatic origin in a patient with metachronous multiple cancers of the renal pelvis and bladder","volume":"56","author":"Takahashi","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.purol.2014.06.010_bib0180","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1245\/s10434-013-3349-z","article-title":"Metastatic behavior of upper tract urothelial carcinoma after radical nephroureterectomy: association with primary tumor location","volume":"21","author":"Tanaka","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.purol.2014.06.010_bib0185","first-page":"65","article-title":"Molecular grading of tumors of the upper urothelial tract using FGFR3 mutation status identifies patients with favorable prognosis","volume":"4","author":"Lyle","year":"2012","journal-title":"Res Rep Urol"},{"key":"10.1016\/j.purol.2014.06.010_bib0190","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/12615","article-title":"Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas","volume":"23","author":"Cappellen","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.purol.2014.06.010_bib0195","doi-asserted-by":"crossref","first-page":"7743","DOI":"10.1158\/1078-0432.CCR-05-1045","article-title":"A simple and fast method for the simultaneous detection of nine fibroblast growth factor receptor 3 mutations in bladder cancer and voided urine","volume":"11","author":"Van Oers","year":"2005","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"10.1016\/j.purol.2014.06.010_bib0200","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1158\/1078-0432.459.11.2","article-title":"Fibroblast growth factor receptor 3 is overexpressed in urinary tract carcinomas and modulates the neoplastic cell growth","volume":"11","author":"G\u00f3mez-Rom\u00e1n","year":"2005","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"10.1016\/j.purol.2014.06.010_bib0205","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.eururo.2008.06.013","article-title":"FGFR3 mutations indicate better survival in invasive upper urinary tract and bladder tumours","volume":"55","author":"Van Oers","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2014.06.010_bib0210","first-page":"244","article-title":"Mutation of the FGFR3 oncogene is an independent and favorable prognostic factor for tumor specific survival in patients with urothelial carcinoma of the upper urinary tract","volume":"90","author":"Burger","year":"2006","journal-title":"Verhandlungen Dtsch Ges F\u00fcr Pathol"},{"key":"10.1016\/j.purol.2014.06.010_bib0215","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2490-12-20","article-title":"Urothelial carcinoma of the upper urinary tract diagnosed via FGFR3 mutation detection in urine: a case report","volume":"12","author":"Silverberg","year":"2012","journal-title":"BMC Urol"},{"key":"10.1016\/j.purol.2014.06.010_bib0220","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/bjc.1995.14","article-title":"Significance of epidermal growth factor receptor and c-erbB-2 protein expression in transitional cell cancer of the upper urinary tract for tumour recurrence at the urinary bladder","volume":"71","author":"Imai","year":"1995","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.purol.2014.06.010_bib0225","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/PAI.0b013e318241cab9","article-title":"Assessment of human epidermal growth factor receptor 2 status in urothelial carcinoma of the upper urinary tract: a study using dual-color in situ hybridization and immunohistochemistry","volume":"20","author":"Vershasselt-Crinquette","year":"2012","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.purol.2014.06.010_bib0230","doi-asserted-by":"crossref","first-page":"8256","DOI":"10.1158\/0008-5472.CAN-09-1689","article-title":"Activation of the PI3K\/AKT pathway induces urothelial carcinoma of the renal pelvis: identification in human tumors and confirmation in animal models","volume":"69","author":"Qian","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.purol.2014.06.010_bib0235","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/ijc.2910640503","article-title":"p53 and human papillomavirus DNA in renal pelvic and ureteral carcinoma including dysplastic lesions","volume":"64","author":"Furihata","year":"1995","journal-title":"Int J Cancer"},{"key":"10.1016\/j.purol.2014.06.010_bib0240","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/(SICI)1096-9896(199602)178:2<133::AID-PATH455>3.0.CO;2-F","article-title":"Detection of p53 and bcl-2 protein in carcinoma of the renal pelvis and ureter including dysplasia","volume":"178","author":"Furihata","year":"1996","journal-title":"J Pathol"},{"key":"10.1016\/j.purol.2014.06.010_bib0245","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.mrrev.2013.02.003","article-title":"Analysis of TP53 mutation spectra reveals the fingerprint of the potent environmental carcinogen, aristolochic acid","volume":"753","author":"Hollstein","year":"2013","journal-title":"Mutat Res"},{"key":"10.1016\/j.purol.2014.06.010_bib0250","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.urology.2004.01.009","article-title":"Prognostic impact of p63 and p53 expression in upper urinary tract transitional cell carcinoma","volume":"63","author":"Zigeuner","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.purol.2014.06.010_bib0255","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/nrurol.2011.92","article-title":"Expression of p53 in upper urinary tract urothelial carcinoma","volume":"8","author":"Mitchell","year":"2011","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.purol.2014.06.010_bib0260","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.clgc.2012.12.009","article-title":"The role of p53 on survival of upper urinary tract urothelial carcinoma: a systematic review and meta-analysis","volume":"11","author":"Ku","year":"2013","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.purol.2014.06.010_bib0265","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.urolonc.2012.10.002","article-title":"Molecular aspects of upper tract urothelial carcinoma","volume":"32","author":"Patel","year":"2014","journal-title":"Urol Oncol"},{"key":"10.1016\/j.purol.2014.06.010_bib0270","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1200\/JCO.2005.03.163","article-title":"Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma","volume":"23","author":"Catto","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.purol.2014.06.010_bib0275","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ejca.2013.08.025","article-title":"Accurate detection of upper tract urothelial carcinoma in tissue and urine by means of quantitative GDF15, TMEFF2 and VIM promoter methylation","volume":"50","author":"Monteiro-Reis","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.purol.2014.06.010_bib0280","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0165-4608(99)00075-8","article-title":"Cytogenetic analysis of upper urinary tract transitional cell carcinomas","volume":"115","author":"Fadl-Elmula","year":"1999","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.purol.2014.06.010_bib0285","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0165-4608(99)00055-2","article-title":"Cytogenetic investigation of transitional cell carcinomas of the upper urinary tract","volume":"114","author":"Dal Cin","year":"1999","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.purol.2014.06.010_bib0290","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0165-4608(00)00426-X","article-title":"Comparative genomic hybridization analysis of transitional cell carcinomas of the renal pelvis","volume":"127","author":"Rigola","year":"2001","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.purol.2014.06.010_bib0295","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/ijc.2910530409","article-title":"Accumulated allelic losses in the development of invasive urothelial cancer","volume":"53","author":"Habuchi","year":"1993","journal-title":"Int J Cancer"},{"key":"10.1016\/j.purol.2014.06.010_bib0300","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/gcc.20803","article-title":"Identification of genetic alterations in upper urinary tract urothelial carcinoma in end-stage renal disease patients","volume":"49","author":"Wu","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.purol.2014.06.010_bib0305","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.eururo.2008.08.008","article-title":"Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (lynch syndrome) tumor spectrum","volume":"54","author":"Roupr\u00eat","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2014.06.010_bib0310","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0022-5347(01)62926-4","article-title":"Urinary tract cancer and hereditary nonpolyposis colorectal cancer: risks and screening options","volume":"160","author":"Sijmons","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2014.06.010_bib0315","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jnci\/djh034","article-title":"Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability","volume":"96","author":"Umar","year":"2004","journal-title":"J Natl Cancer Inst"},{"issue":"11 Pt B","key":"10.1016\/j.purol.2014.06.010_bib0320","first-page":"E583","article-title":"A proportion of hereditary upper urinary tract urothelial carcinomas are misclassified as sporadic according to a multi-institutional database analysis: proposal of patient-specific risk identification tool","volume":"110","author":"Audenet","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.purol.2014.06.010_bib0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.purol.2014.06.012","article-title":"\u00c9pid\u00e9miologie et facteurs de risque des tumeurs de la voie excretrice urinaire sup\u00e9rieure\u00a0: revue de la litt\u00e9rature pour le rapport annuel de l\u2019Association fran\u00e7aise d\u2019urologie","author":"Ouzzane","year":"2014","journal-title":"Prog Urol"},{"key":"10.1016\/j.purol.2014.06.010_bib0330","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.juro.2011.10.038","article-title":"Genetic variability in 8q24 confers susceptibility to urothelial carcinoma of the upper urinary tract and is linked with patterns of disease aggressiveness at diagnosis","volume":"187","author":"Roupr\u00eat","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2014.06.010_bib0335","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.jhazmat.2012.08.056","article-title":"Comparing the joint effect of arsenic exposure, cigarette smoking and risk genotypes of vascular endothelial growth factor on upper urinary tract urothelial carcinoma and bladder cancer","volume":"262","author":"Wang","year":"2013","journal-title":"J Hazard Mater"},{"key":"10.1016\/j.purol.2014.06.010_bib0340","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1158\/1055-9965.EPI-07-0361","article-title":"Phenol sulfotransferase SULT1A1*2 allele and enhanced risk of upper urinary tract urothelial cell carcinoma","volume":"16","author":"Roupr\u00eat","year":"2007","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.purol.2014.06.010_bib0345","doi-asserted-by":"crossref","DOI":"10.1007\/s13277-014-1954-5","article-title":"Association between the SULT1A1 Arg213His polymorphism and the risk of bladder cancer: a meta-analysis","author":"Su","year":"2014","journal-title":"Tumour Biol J Int Soc Oncodevelopmental Biol Med"},{"key":"10.1016\/j.purol.2014.06.010_bib0350","doi-asserted-by":"crossref","first-page":"196","DOI":"10.4077\/CJP.2011.AMM123","article-title":"Potential role of CCND1 G870A genotype as a predictor for urothelial carcinoma susceptibility and muscle-invasiveness in Taiwan","volume":"54","author":"Lin","year":"2011","journal-title":"Chin J Physiol"},{"key":"10.1016\/j.purol.2014.06.010_bib0355","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1593\/neo.07982","article-title":"DNA repair gene polymorphisms may be associated with prognosis of upper urinary tract transitional cell carcinoma","volume":"10","author":"Sasaki","year":"2008","journal-title":"Neoplasia"},{"key":"10.1016\/j.purol.2014.06.010_bib0360","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1755-8794-3-58","article-title":"Comparative gene expression profiling analysis of urothelial carcinoma of the renal pelvis and bladder","volume":"3","author":"Zhang","year":"2010","journal-title":"BMC Med Genomics"}],"container-title":["Progr\u00e8s en Urologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708714001882?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708714001882?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T06:25:54Z","timestamp":1761114354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1166708714001882"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":72,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S1166708714001882"],"URL":"https:\/\/doi.org\/10.1016\/j.purol.2014.06.010","relation":{},"ISSN":["1166-7087"],"issn-type":[{"value":"1166-7087","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Voies de carcinogen\u00e8se et histoire naturelle des tumeurs de la voie excr\u00e9trice sup\u00e9rieure\u00a0: \u00e9tat de l\u2019art pour le rapport annuel de l\u2019Association fran\u00e7aise d\u2019urologie","name":"articletitle","label":"Article Title"},{"value":"Progr\u00e8s en Urologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.purol.2014.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}